Bay Street News, 2020

REDWOOD CITY, Calif. and PITTSBURGH, Pa., Jan. 12, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH), a leading precision […]

COPENHAGEN, Denmark, Jan. 12, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative […]

WARREN, N.J., Jan. 12, 2020 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company focused on developing […]

— OPTIC phase 1 trial progressing with plans to complete patient dosing in cohort three, begin enrollment in cohort four […]

– Total preliminary net product sales of approximately $108 million for the fourth quarter and approximately $309 million for the […]

SAN CARLOS, Calif., Jan. 12, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel […]

RESEARCH TRIANGLE PARK, N.C., Jan. 12, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will […]

SAN CARLOS, Calif. and NEW YORK, Jan. 12, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology […]

– In 2025, Company Expects to Have 4 Marketed Products in at Least 8 Indications, at Least 6 Molecules in […]

Key milestones anticipated across Atara’s four strategic priorities in 2020Continued investment in EBV T-cell platform to develop off-the-shelf, allogeneic CAR […]